Jade M van Berge Henegouwen
6PUBLICATIONS
48CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jul 18, 2024
The Innate Immune Landscape of dMMR/MSI Cancers Predicts the Outcome of Nivolumab Treatment: Results from the Drug Rediscovery Protocol.Laurien J Zeverijn, Birgit S Geurts, Thomas W Battaglia
|Jun 27, 2024
Maximizing Treatment Opportunities: Assessing Protocol Waivers' Impact on Safety and Outcome in the Drug Rediscovery Protocol.Jade M van Berge Henegouwen, Laurien J Zeverijn, Birgit S Geurts
|May 15, 2024
Characterization of discordance between mismatch repair deficiency and microsatellite instability testing may prevent inappropriate treatment with immunotherapy.Birgit S Geurts, Laurien J Zeverijn, Jade M van Berge Henegouwen
|Apr 17, 2024
Efficacy of Pembrolizumab and Biomarker Analysis in Patients with WGS-Based Intermediate to High Tumor Mutational Load: Results from the Drug Rediscovery Protocol.Birgit S Geurts, Laurien J Zeverijn, Lindsay V M Leek
|Jan 20, 2022
Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment.Louisa R Hoes, Jade M van Berge Henegouwen, Hanneke van der Wijngaart
|Sep 03, 2021
Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types.Hanneke van der Wijngaart, Louisa R Hoes, J Maxime van Berge Henegouwen
Pageof 1
Frequent Collaborators
6 joint publications
Hanneke van der Wijngaart
6 joint publications
Hans Gelderblom
6 joint publications
Henk Mw Verheul
5 joint publications
Anne Ml Jansen
4 joint publications
Laurien J Zeverijn
4 joint publications
Birgit S Geurts
4 joint publications
Carla Ml van Herpen
4 joint publications
Wendy Wj de Leng
4 joint publications
Vincent van der Noort
4 joint publications
Louisa R Hoes
